Hemostasis Products Market Analysis 2024-2033 : Market Size, Top Segments, Leading Region Forecast | Pfizer Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Medtronic plc, Johnson And Johnson Pvt. Ltd

"The new report published by The Business Research Company, titled ""Hemostasis Products Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the hemostasis products market size has grown strongly in recent years. It will grow from $1.59 billion in 2023 to $1.7 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The hemostasis products market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13244&type=smp

Increase In The Prevalence Of Blood Disorders Boost The Market For Hemostasis Products
The increase in the prevalence of blood disorders is expected to propel the growth of the hemostasis products market going forward. Blood disorders, also known as hematologic disorders, refer to a group of medical conditions that affect the composition, function, and behavior of blood and its components. Hemostasis products are used in various blood disorders to help regulate the clotting and bleeding processes in the body. It can address both excessive bleeding (hemorrhage) and excessive clotting (thrombosis) that can occur in different blood disorders. For instance, in June 2021, according to the Leukemia Foundation, an Australia-based non-profit organization, there were approximately 110,000 people living with blood disorders in Australia in 2021. By 2035, it is expected that this number will increase to more than 275,000 cases due to the rise in the incidence of blood cancer and blood disorders in Australia. Therefore, an increase in the prevalence of blood disorders is driving the growth of the hemostasis products market.

Increasing Focus On Product Approvals To Drive The Revenues
Major companies operating in the hemostasis products market are developing innovative drugs such as the Nexpowder endoscopic hemostasis system and getting approval to have a full range of active and passive hemostatic products for bleeding control. An endoscopic hemostasis system is a medical device and technique used to control bleeding in the gastrointestinal (GI) tract during endoscopic procedures. For instance, in September 2022, Medtronic plc, a US-based medical device company received clearance from the U.S. Food and Drug Administration for the Nexpowder Endoscopic Hemostasis System for the treatment of nonvariceal upper GI bleeding. This innovative hemostatic product is designed to be used in conjunction with endoscopy. Moreover, it has the potential to make a significant impact on the treatment of nonvariceal upper GI bleeding as it is easy to use, effective, and well-tolerated.

The hemostasis products market covered in this report is segmented -

1) By Product: Topical Hemostasis Product, Infusible Hemostasis Product, Advanced Hemostasis Product
2) By Application: Trauma, Surgery, Hemophilia, Myocardial Infarction, Other Applications
3) By End User: Hospitals, Clinics, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13244&type=discount

Major companies operating in the hemostasis products market report are Pfizer Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Medtronic plc, Johnson And Johnson Pvt. Ltd., Siemens Healthineers, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., BBraun Melsungen AG, Fresenius Kabi AG, Zimmer Biomet Holdings Inc., Olympus Corporation, Grifols S.A., Terumo BCT Inc., Smith And Nephew plc, Ethicon Suture Laboratories, Hologic Inc., Cook Medical, Teleflex Incorporated, Integra LifeSciences Corporation, Haemonetics Corporation, Z-Medica LLC, Tricol Biomedical, Hem Con Medical Technologies Inc., Hemostasis LLC, C. R. Bard Inc., CuraMedical BV

Contents of the report:
1. Executive Summary
2. Hemostasis Products Market Report Structure
3. Hemostasis Products Market Trends And Strategies
4. Hemostasis Products Market - Macro Economic Scenario
5. Hemostasis Products Market Size And Growth
…..
27. Hemostasis Products Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.